Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-032330

EVP, Research & CSO sold 3,805 shares at $34.08 ($129,674)

  • EVP, Research & CSO acquired 3,805 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2020-05-26 Option exercise +3,805 $1.53 $5,822 3,805 D: show line 1 in the form
Virgin Herbert EVP, Research & CSO 2020-05-26 Sale −3,805 $34.08 $129,674 0 D: show line 2 in the form
Open-market sales · 3,805 sh · avg $34.08 · $129,674

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Virgin Herbert EVP, Research & CSO 2020-05-26 Option exercise · Stock Option (Right to Buy) −3,805 546,190 D: show line 3 in the form
Loading xslF345X03/doc4.xml…